MACM
IART icon

March Altus Capital Management’s Integra LifeSciences IART Stock Holding History

March Altus Capital Management’s Portfolio IART Stock Details IART Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-315,698
Closed -$5.93M – 33
2014
Q1 		$5.93M Sell
315,698
-309,146
-49% -$5.97M 1.91% 27
2013
Q4 		$12.2M Buy
+624,844
New +$11.5M 3.69% 8

Other funds holding IART

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

March Altus Capital Management's IART Position: Q2 2014 in Review

March Altus Capital Management sold out of Integra LifeSciences (IART) in Q2 2014, closing a stake of 315,698 shares — an estimated $5.93M sold.

March Altus Capital Management first reported a position in IART in Q4 2013 and held it in 2 quarters. The position peaked at $12.2M in Q4 2013. 147 funds tracked by Wall St. Rank hold IART as of Q2 2014.

  • March Altus Capital Management reported no remaining Integra LifeSciences position as of Q2 2014 after selling out during the quarter.
  • March Altus Capital Management sold 315,698 Integra LifeSciences shares in Q2 2014, an estimated $5.93M.
  • March Altus Capital Management first reported a position in Integra LifeSciences in Q4 2013 and held it in 2 quarters.
  • March Altus Capital Management's Integra LifeSciences position peaked at $12.2M in Q4 2013.
  • 147 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2014.

Based on March Altus Capital Management's 13F filing for Q2 2014, filed 14 Aug 2014.